Non-improvement of atrophic gastritis in cases of gastric cancer after successful Helicobacter pylori eradication therapy

doi:10.12998/wjcc.v12.i14.2342

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1757)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

HTML

1130

Figures (1-3)

146

Tables (1-4)

153

Sum=1471

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

156

Sum=224

May 16, 2024 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. May 16, 2024; 12(14): 2342-2349
Published online May 16, 2024. doi: 10.12998/wjcc.v12.i14.2342

Table 3 Patients’ characteristics

Characteristics	Gastric cancer	Gastritis	P value
Number	30	30
Age (yr ± SD)	75.3	73.9	0.695
Sex (M:F)	21:9	17:13	0.422
Differentiation (tub1-2: Sig-por)	29:1
Depth (m: Sm)	30:0

SD: Standard deviation; tub1-2: Well to moderate differentiated adenocarcinoma; sig: Signet ring cell carcinoma; por: Poorly differentiated adenocarcinoma; m: Mucosa; Sm: Submucosa.

Citation: Suzuki Y, Katayama Y, Fujimoto Y, Kobori I, Tamano M. Non-improvement of atrophic gastritis in cases of gastric cancer after successful Helicobacter pylori eradication therapy. World J Clin Cases 2024; 12(14): 2342-2349
URL: https://www.wjgnet.com/2307-8960/full/v12/i14/2342.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i14.2342